Renata Silverio

Prof. Renata Silverio

Universidade de São Paulo, São Paulo, Brazil
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 February 2013 in Cytokine
Verified
Journal Article
Closed access
MJMiguel Luiz Batista Jr.
Miguel Luiz Batista Jr.
MOM. Olivan
M. Olivan
PAP.S.M. Alcantara
P.S.M. Alcantara
RSR. Sandoval
R. Sandoval
SPS.B. Peres
S.B. Peres
MSMarilia Seelaender
Marilia Seelaender

25 September 2020 in Advances in Nutrition
Verified
Journal Article
Open access
PDF file
Renata SilverioRenata Silverio
Renata Silverio
Daniela Caetano GonçalvesDaniela Caetano Gonçalves
Daniela Caetano Gonçalves
MAMárcia Fábia Andrade
Márcia Fábia Andrade
MSMarilia Seelaender
Marilia Seelaender
Coronavirus disease 2019 (COVID-19) is an emerging disease that has reached pandemic status by rapidly spreading worldwide. Elderly individuals and patients with comorbidities such as obesity, diabetes, and hypertension show a higher risk of hospitalization, severe disease, and mortality by acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. These patients frequently show exacerbated secretion of proinflammatory cytokines associated with an overreaction of the immune system, the so-called cytokine storm. Host nutritional status plays a pivotal role in the outcome of a variety of different infectious diseases. It is known that the immune system is highly affected by malnutrition, leading to decreased immune responses with consequent augmented risk of infection and disease severity. Body composition, especially low lean mass and high adiposity, has consistently been linked to worsened prognosis in many different diseases. In this review, evidence concerning the impact of nutritional status on viral infection outcomes is discussed.

26 January 2011 in Journal of Cachexia, Sarcopenia and Muscle
Verified
Journal Article
Open access
PDF file
Renata SilverioRenata Silverio
Renata Silverio
ALAlessandro Laviano
Alessandro Laviano
Filippo RossiFilippo Rossi
Filippo Rossi
MSMarilia Seelaender
Marilia Seelaender
Cancer cachexia is a multifaceted syndrome characterized, among many symptoms, by extensive muscle wasting. Chronic systemic inflammation, partly triggered and sustained by cytokines, as well as increased oxidative stress contributes to the pathogenesis of this complex metabolic disorder.l‐carnitine plays a central role in the metabolism of fatty acids and shows important antioxidant and anti‐inflammatory properties. Systemic carnitine depletion has been described in several diseases, and it is characterized by fatigue, muscle weakness, and decreased tolerance to metabolic stress. In cachectic cancer patients, low serum carnitine levels have been reported, and this change has been suggested to play an important contributory role in the development of cachexia. Based on these data, carnitine supplementation has been tested in preliminary studies concerning human cachexia, resulting in improved fatigue and quality of life. We present here a review of clinical and experimental evidence regarding the use of carnitine supplementation in the management of cancer cachexia.

1 August 2012 in Clinical Nutrition
Verified
Journal Article
Closed access
MSMarilia Seelaender
Marilia Seelaender
MJMiguel Luiz Batista Jr.
Miguel Luiz Batista Jr.
FLFabio Lira
Fabio Lira
Renata SilverioRenata Silverio
Renata Silverio
Filippo RossiFilippo Rossi
Filippo Rossi

22 August 2017 in Lipids in Health and Disease
Verified
Journal Article
Open access
PDF file
Renata SilverioRenata Silverio
Renata Silverio
FLFábio S. Lira
Fábio S. Lira
LOLila M. Oyama
Lila M. Oyama
CNCLAUDIA M. PENHA OLLER DO NASCIMENTO
CLAUDIA M. PENHA OLLER DO NASCIMENTO
JOJosé P. Otoch
José P. Otoch
MSMarilia Seelaender
Marilia Seelaender
Cancer cachexia is a multifactorial metabolic syndrome characterized by marked loss of adipose tissue and skeletal muscle. Fat loss from adipose tissue in cancer cachexia is partly the result of increased lipolysis. Despite the growing amount of studies focused on elucidating the mechanisms through which lipolysis-related proteins regulate the lipolytic process, there are scarce data concerning that profile in the adipose tissue of cancer cachectic patients. Considering its fundamental importance, it was our main purpose to characterize the expression of the lipolysis-related proteins in the white adipose tissue of cachectic cancer patients. Patients from the University Hospital were divided into three groups: control, cancer cachexia (CC), and weight-stable cancer patients (WSC). To gain greater insight into adipose tissue wasting during cancer cachexia progression, we have also analyzed an experimental model of cachexia (Walker 256 carcinosarcoma). Animals were divided into: control, intermediate cachexia (IC) and terminal cachexia (TC). Subcutaneous white adipose tissue of patients and epidydimal white adipose tissue of animals were investigated regarding molecular aspects by determining the protein content and gene expression of hormone-sensitive lipase (HSL), adipose triglyceride lipase (ATGL), comparative gene identification-58 (CGI-58), perilipin 1, leptin, adiponectin, visfatin, and tumour necrosis factor alpha (TNF-alpha). We found augmented lipolysis in CC associated with increased HSL expression, as well as upregulation of ATGL expression and reduction in perilipin 1 content. In IC, there was an imbalance in the secretion of pro- and anti-inflammatory factors. The alterations at the end-stage of cachexia were even more profound, and there was a reduction in the expression of almost all proteins analyzed in the animals. Our findings show that cachexia induces important morphological, molecular, and humoral alterations in the white adipose tissue, which are specific to the stage of the syndrome.

5 April 2011 in Amino Acids
Verified
Journal Article
Closed access
PDF file
Renata SilverioRenata Silverio
Renata Silverio
ALAlessandro Laviano
Alessandro Laviano
Filippo RossiFilippo Rossi
Filippo Rossi
MSMarilia Seelaender
Marilia Seelaender